...
首页> 外文期刊>International Journal of Molecular Sciences >Long-Term Anti-Allodynic Effect of Immediate Pulsed Radiofrequency Modulation through Down-Regulation of Insulin-Like Growth Factor 2 in a Neuropathic Pain Model
【24h】

Long-Term Anti-Allodynic Effect of Immediate Pulsed Radiofrequency Modulation through Down-Regulation of Insulin-Like Growth Factor 2 in a Neuropathic Pain Model

机译:通过下调胰岛素样生长因子2在神经性疼痛模型中立即脉冲射频调制的长期抗痛觉过敏作用。

获取原文
           

摘要

Pulsed radiofrequency (PRF) is effective in the treatment of neuropathic pain in clinical practice. Its application to sites proximal to nerve injury can inhibit the activity of extra-cellular signal-regulated kinase (ERK) for up to 28 days. The spared nerve injury (SNI)+ immPRF group (immediate exposure to PRF for 6 min after SNI) exhibited a greater anti-allodynic effect compared with the control group (SNI alone) or the SNI + postPRF group (application of PRF for 6 min on the 14th day after SNI). Insulin-like growth factor 2 (IGF2) was selected using microarray assays and according to web-based gene ontology annotations in the SNI + immPRF group. An increase in IGF2 and activation of ERK1/2 were attenuated by the immPRF treatment compared with an SNI control group. Using immunofluorescent staining, we detected co-localized phosphorylated ERK1/2 and IGF2 in the dorsal horn regions of rats from the SNI group, where the IGF2 protein predominantly arose in CD11b- or NeuN-positive cells, whereas IGF2 immunoreactivity was not detected in the SNI + immPRF group. Taken together, these results suggest that PRF treatment immediately after nerve injury significantly inhibited the development of neuropathic pain with a lasting effect, most likely through IGF2 down-regulation and the inhibition of ERK1/2 activity primarily in microglial cells.
机译:脉冲射频(PRF)在临床实践中可有效治疗神经性疼痛。它在神经损伤附近部位的应用可以抑制细胞外信号调节激酶(ERK)的活性长达28天。备用神经损伤(SNI)+ immPRF组(SNI后立即暴露于PRF 6分钟)与对照组(仅SNI)或SNI + postPRF组(应用PRF 6分钟)相比,显示出更大的止痛作用。在SNI之后的第14天)。使用微阵列测定法并根据SNI + immPRF组中基于网络的基因本体注释选择胰岛素样生长因子2(IGF2)。与SNI对照组相比,通过immPRF治疗可减轻IGF2的增加和ERK1 / 2的激活。使用免疫荧光染色,我们从SNI组的大鼠的背角区域中检测到共定位的磷酸化ERK1 / 2和IGF2,其中IGF2蛋白主要出现在CD11b或NeuN阳性细胞中,而在SNI组中未检测到IGF2免疫反应性SNI + immPRF组。综上,这些结果表明,神经损伤后立即进行PRF治疗可显着抑制神经性疼痛的发展,并具有持久作用,这很可能主要是通过IGF2下调和主要在小胶质细胞中抑制ERK1 / 2活性来实现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号